TelyRx Holdings Inc. experienced a notable decline in its stock price during yesterday's trading session, raising concerns among investors.
In yesterday's trading session, TelyRx Holdings Inc. (TELY.TO) saw its stock price drop by 4.08%, closing at CA$2.35. This decline comes as the company navigates a challenging market environment, despite recent announcements about its financial performance.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$69.14M
52W high
$4.25
52W low
$2.00
1W change
+10.64%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 130.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+130.8% Upside
Current Price
C$2.60
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
60.6%
Annualized
90-Day Vol
88.9%
Annualized
Trend (90d)
+25.0%
Annualized drift
90d Mean
C$2.84
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.68 | C$2.17 – C$3.30 |
| 60 trading days | C$2.76 | C$2.05 – C$3.71 |
| 90 trading days | C$2.84 | C$1.98 – C$4.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious, as TelyRx's recent stock performance reflects underlying market pressures and potential volatility ahead.
Stock down 4.08% in one day
TelyRx's market cap stands at CA$65.1 million, suggesting that investor confidence may be wavering as the company faces scrutiny over its operational performance.
Bull case
TelyRx has reported significant revenue growth in its recent financial results, showing strong demand for its digital pharmacy services. This growth indicates potential for future profitability, which could reassure investors looking for positive signs.
Bear case
The stock's recent decline highlights investor skepticism, likely stemming from concerns about the company's ability to maintain its growth trajectory amid increasing competition and market challenges.
Market Reaction
Advertisement
The 4.08% decline in TelyRx's stock price yesterday signals a potential shift in investor sentiment. Despite previous announcements of revenue growth, the market's reaction suggests that investors are weighing the company's future prospects against current challenges.
Financial Performance Overview
TelyRx recently reported a significant increase in revenue, with figures rising to CA$42.9 million for the year ended December 31, 2025. However, the stock's fall yesterday indicates that investors may be worried about sustaining this growth and the overall market conditions affecting the company. For more details on TelyRx's financial results, check out the full report on TelyRx's financial performance.
Looking Ahead
As TelyRx navigates its growth trajectory, investors should keep an eye on upcoming announcements and market trends. The recent stock performance emphasizes the importance of staying informed about the company's developments and potential risks. For further insights, visit TelyRx stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
